Catalyst Event

Moderna Inc (MRNA) · Other

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

6/2/2026, 12:00:00 AM

OtherSentiment: Positive

Moderna announced an expanded collaboration with CEPI to develop a vaccine candidate against the Bundibugyo ebolavirus on June 2, 2026; while positive, the funding amount is relatively small, likely resulting in ≥1% price impact, scheduled.

Korean Translation

2026년 6월 2일 CEPI와 에볼라 발표 백신 개발 협력 확대를 발표할 예정임. 긍정적 소식이나 자금 규모를 고려할 때 1-5% 수준의 주가 영향이 예상됨.

Related Recent Events

View Full Timeline